A Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2018
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 16 Jun 2018 Results (n=396) presented at the 19th Annual Congress of the European League Against Rheumatism.
- 06 Dec 2017 Status changed from recruiting to completed.
- 04 May 2016 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017.